- HIV+ community stage protest to drop harmful provisions in RCEP; arrested & released
- Trading away health
- Regional Comprehensive Economic Partnership: Boosting trade or extending monopolies for big pharma?
- Hyderabad: NGOs hold protest against RCEP talks
- A Trade Deal Could Hit Affordable & Generic Medicines in India. Here’s What You Need to Know.
Category Archives: US Pressure
By Nayanima Basu, The Hindu BusinessLine | JUNE 27, 2017 India’s Intellectual Property Rights (IPR) and patent law enforcement as well New Delhi’s decision to cap prices of medical devices remained a contentious issue with the US even during Prime Minister … Continue reading
Source: Politico | June 26, 2017 TRUMP’S CHANCE TO RESET THE INDIA TRADE RELATIONSHIP: Indian Prime Minister Narendra Modi is meeting with President Donald Trump at the White House today, where they are expected to broach a wide-range of issues, … Continue reading
The Trump Executive Order on drug prices: not what was promised nor needed, and contrary to US self interest
Source: Medium Emily Kopp has a big scoop for Kaiser Health News. She has obtained a six page document outlining the draft provisions or objectives of a proposed Presidential Executive Order (EO) on drug prices. She has shared some of … Continue reading
The US government is stepping up on TRIPS plus pressure through bilateral forums based on a US law that passed under Obama to strengthen IPR enforcement and the 301 process. Countries targeted include India, Indonesia, China, Thailand, Ukraine in Asia … Continue reading